MYC Protein No Longer Appears Undruggable in Prostate Cancer, Preclinical Data Shows

In an interview with Targeted Oncology, Sarki Abdulkadir, MD, PhD, discussed the emerging role of the MYC protein as a target for the treatment of patients with prostate cancer.

Read the full article here

Related Articles